Document Detail

Effects of procainamide on automatic and triggered impulse initiation in isolated preparations of canine cardiac Purkinje fibers.
MedLine Citation:
PMID:  2459539     Owner:  NLM     Status:  MEDLINE    
The effects of procainamide (40 mg/L) were studied on automatic and triggered impulse initiation in isolated preparations of canine cardiac Purkinje fibers using standard microelectrode techniques. Procainamide decreased normal automaticity by 48% in Purkinje fibers superfused with standard (KCl 4 mM) Tyrode's solution. In contrast, procainamide decreased the rate of normal Purkinje fibers that had been treated with isoproterenol (1 microM) by only 6% (NS). For comparison, the effects of lidocaine (4 mg/L) and quinidine (5 mg/L) were studied on isoproterenol-treated fibers. Lidocaine and quinidine both significantly decreased the isoproterenol-enhanced rate of normal automaticity (by 45 and 10%, respectively). In studies of the effects of procainamide on Purkinje fibers with abnormal automaticity (i.e., the pacemakers had maximal diastolic potentials less than -60 mV), it was found that drug treatment decreased the rate of 24 h infarct zone Purkinje fibers by 22% and barium chloride (250 microM) treated Purkinje fibers by 51%. In studies of another five infarct zone preparations, the Purkinje fibers had maximal diastolic potentials greater than -75 mV and showed triggered activity with delayed afterdepolarizations. Procainamide decreased the triggered activity in only one of these preparations. Ventricular tachycardias that respond to procainamide may be caused by abnormal automaticity, whereas procainamide refractory tachycardias may result from triggered activity or from catecholamine-enhanced normal automaticity.
K H Dangman
Related Documents :
1149509 - An electrocardiographic pattern of acute myocardial infarction associated with excessiv...
835719 - Effects of intravenous anesthetic agents on left ventricular function in dogs.
14566399 - Bmk i, an alpha-like scorpion neurotoxin, specifically modulates isolated rat cardiac m...
633069 - Antiarrhythmic, metabolic and hemodynamic effects of org 6001 (3alpha-amino-5alpha-andr...
8011559 - Effects of beta-blockers and ca(2+)-antagonists on the response of the isolated working...
3012099 - Prevention of ventricular fibrillation by metoprolol in a pig model of acute myocardial...
9391229 - The physiologic cause of swallowing sounds: answers from heart sounds and vocal tract a...
20206079 - A novel echocardiographic index of inefficient left ventricular contraction resulting f...
12047779 - Ventricular interdependence in patients with dual-chamber pacing: a doppler tissue imag...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  12     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1988 Jul 
Date Detail:
Created Date:  1988-11-08     Completed Date:  1988-11-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  78-87     Citation Subset:  IM    
Department of Pharmacology, College of Physicians and Surgeons of Columbia University, New York, NY 10032.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Action Potentials / drug effects
Barium / pharmacology
Barium Compounds*
Heart Conduction System / drug effects*
Isoproterenol / pharmacology
Lidocaine / pharmacology
Procainamide / pharmacology*
Purkinje Fibers / drug effects*,  physiology
Quinidine / pharmacology
Grant Support
Reg. No./Substance:
0/Barium Compounds; 0/Chlorides; 10361-37-2/barium chloride; 137-58-6/Lidocaine; 51-06-9/Procainamide; 56-54-2/Quinidine; 7440-39-3/Barium; 7683-59-2/Isoproterenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hemodynamic effects of a constant intravenous infusion of piroximone in patients with severe congest...
Next Document:  Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin s...